Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Parkinson disease

What goes around comes around: cognitive impairment as prodromal parkinsonism?

Patients with prodromal Parkinson disease (PD) are most likely to respond to disease-modifying strategies. To date, cognitive impairment has been viewed as a complication of late-stage disease, but a longitudinal analysis of data from the Rotterdam cohort raises the possibility that such impairments are also associated with prodromal PD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Aarsland, D. et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13, 217–231 (2017).

    Article  Google Scholar 

  2. Berg, D. et al. MDS research criteria for prodromal Parkinson's disease. Mov. Disord. 30, 1600–1611 (2015).

    Article  Google Scholar 

  3. Athauda, D. & Foltynie, T. Challenges in detecting disease modification in Parkinson's disease clinical trials. Parkinsonism Relat. Disord. 32, 1–11 (2016).

    Article  Google Scholar 

  4. Darweesh, S. K. L. et al. Association between poor cognitive functioning and risk of incident parkinsonism: the Rotterdam study. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2017.2248 (2017).

  5. Iranzo, A. et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 9, 1070–1077 (2010).

    Article  CAS  Google Scholar 

  6. Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 24, 197–211 (2003).

    Article  Google Scholar 

  7. Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord. 30, 1591–1601 (2015).

    Article  Google Scholar 

  8. Compta, Y. et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 134, 1493–1505 (2011).

    Article  Google Scholar 

  9. Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629–635 (2011).

  10. Noyce, A. J. et al. PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results. J. Neurol. Neurosurg. Psychiatry 85, 31–37 (2014).

    Article  Google Scholar 

Download references

Acknowledgements

Y.C. and M.J.M. gratefully acknowledge financial support from the CERCA Programme of the Generalitat de Catalunya (Barcelona, Catalonia, Spain).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria J. Martí.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Compta, Y., Martí, M. What goes around comes around: cognitive impairment as prodromal parkinsonism?. Nat Rev Neurol 13, 709–710 (2017). https://doi.org/10.1038/nrneurol.2017.159

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2017.159

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing